Can multisite clinical trial results change clinical practice? Use of long-acting injectable risperidone nationally in the Veterans Health Administration
ConclusionsThe declining use of LAI risperidone likely primarily reflects the substitution of a longer-acting LAI SGA, paliperidone, that came to market 2 yearsbefore the study publication, a substitution that may have been reinforced by null CSP#555 study results for LAI risperidone. (Source: Trials)
Source: Trials - February 6, 2023 Category: Research Source Type: clinical trials
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
Condition: Schizophrenia Interventions: Drug: SEP-363856; Drug: Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole) Sponsor: Sunovion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2022 Category: Research Source Type: clinical trials
Non-interventional Study of Risperidone ISM ® in Schizophrenia Patients Hospitalised Due to a Relapse
Condition: Schizophrenia Intervention: Drug: Risperidone ISM Sponsor: Rovi Pharmaceuticals Laboratories Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
